Archive - January 2020
FDA starts priority review of BMS Opdivo/Yervoy in first-line NSCLC
Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
Lilly ends $1.4bn deal with immuno-oncology biotech NextCure
Janssen submits Spravato expansion in EU
A&E to scrap waiting targets?
NICE ‘OK’ for Lynparza
Scientists discover ‘skin cancer suppressor’
Best Vitamin D Sources For Everyone